MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Mermillod et al. estimated the carbon footprint of the Geneva healthcare system. The study identifies key emission contributors, highlighting medicines and medical devices as the dominant global emission sources (59%). When excluding these, hospitals emerge as the primary source of emissions (48%), followed by nursing homes and private practices. The authors outlined direct and systemic strategies for reduction, including optimizing prescription practices, energy use, and transportation. The findings provide a foundation for policymakers to implement ambitious carbon reduction policies in healthcare.

In late January 2025, the Nordic Initiative for Environmental Labelling of Medical Supplies (NIELS) project was completed. The initiative was aimed to promote greener procurement of medical equipment by expanding the use of eco-labeling. Following its successful conclusion, the project is now considering opportunities to broaden the dialogue to a European level.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Elvidge et al. introduced the CHEERS-AI checklist, a standardized reporting framework for economic evaluations of AI-based health interventions. Developed through a Delphi study with multidisciplinary experts, the checklist comprises 38 reporting items, including AI-specific considerations. By improving transparency and reproducibility, CHEERS-AI aims to enhance the quality of cost-effectiveness assessments and facilitate informed decision-making in AI-driven healthcare.

In February and March 2025, the Common Catalog of Genetic and Genomic Tests of the National Health System was updated in Spain. A new section, “Hepatic diseases,” was added, including 24 tests for multiple hepatic diseases.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Manetti et al. conducted a systematic literature review to assess how real-world evidence (RWE) and real-world data are utilized in post-market evaluations of medical devices. The authors analyzed 145 research articles and found that most assessments relied on administrative databases, with economic and clinical evidence being the most reported outcomes. The findings underscored gaps in incorporating patient perspectives and organizational impact, providing valuable insights for policymakers and researchers in shaping future RWE frameworks for medical devices.

On February 25, 2025, the Institute for Quality and Efficiency in Health Care (IQWiG) presented an updated draft version (8.0) of its general methods. Interested parties can submit written comments until April 29, 2025.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Gentilini et al. critically examined the European Commission’s 2024 Implementing Regulation on conflict-of-interest management in the EU Joint Clinical Assessment (JCA). A review of national HTA policies showed that the new conflict-of-interest management approach is largely modeled after French HTA guidelines. The authors identified concerns related to expert representativeness, disclosure clarity, and enforcement challenges. These findings highlighted the need for greater transparency and resource allocation to ensure an impartial assessment process.

On March 13, 2025, a major organizational reform was announced by the Department of Health and Social Care (DHSC). It is planned to abolish the NHS England and reintegrate its functions into the DHSC. The initiative aims to reduce bureaucracy, eliminate duplication between the two bodies, improve efficiency, and cut costs. The transition is expected to be completed within the next two years.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Value-Based Publications Digest. In a recent publication, Rickers et al. introduced a new optimization model for the multiproduct dynamic order quantity problem, aiming to enhance procurement decisions for reusable medical devices. The model integrates product returns and reprocessing parameters and considers the limited shelf life of sterile devices and capacity constraints in sterilization and reprocessing resources. Numerical simulations demonstrated significant cost reductions compared to conventional first-come-first-served approaches, highlighting the practical advantages of integrated procurement planning.

On February 21, 2025, the “New Method” framework published an annual summary of the Decision Forum and Ordering Forum work in 2024. Among 109 coverage decisions in 2024, only one was for Med Tech (Oncotype DX), while all others concerned pharmaceuticals.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Iakovou et al. conducted a systematic review evaluating sustainability initiatives in plastic surgery, analyzing data on carbon emissions, waste management, and procedural costs. Based on data from 15 studies, hand surgery emerged as the leading subspecialty driving sustainability practices, complemented by notable efforts in craniofacial, skin cancer, and breast surgery. Notably, effective recycling programs redirected an average of 39.6 tonnes of waste per month, and the average carbon footprint was calculated as 22.7 kgCO2-eq per procedure.

In February 2025, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedures Guidance on intravascular lithotripsy during percutaneous coronary intervention. Furthermore, one clinical guideline was updated.